Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments

Recruiting

Phase 2

Phase 3

Buprenorphine/Naloxone vs. Standard DosingEvaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments

Sponsor:

University of British Columbia

Code:

NCT04893525

Conditions

Opioid-use Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Buprenorphine/naloxone

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-04. This information was provided to ClinicalTrials.gov by University of British Columbia on 2024-02-29.